Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Anika Therapeutics (ANIK) Exchange Rate Effect (2016 - 2026)

Anika Therapeutics has reported Exchange Rate Effect over the past 17 years, most recently at -$29000.0 for Q1 2026.

Quarterly Exchange Rate Effect fell 126.85% to -$29000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$51000.0 through Mar 2026, down 156.04% year-over-year, with the annual reading at $86000.0 for FY2025, 279.17% up from the prior year.
Exchange Rate Effect was -$29000.0 for Q1 2026 at Anika Therapeutics, up from -$65000.0 in the prior quarter.
Over five years, Exchange Rate Effect peaked at $345000.0 in Q2 2025 and troughed at -$302000.0 in Q3 2025.
The 5-year median for Exchange Rate Effect is -$29000.0 (2026), against an average of -$2470.6.
Year-over-year, Exchange Rate Effect soared 850.0% in 2023 and then tumbled 929.63% in 2024.
A 5-year view of Exchange Rate Effect shows it stood at -$69000.0 in 2022, then skyrocketed by 210.14% to $76000.0 in 2023, then crashed by 271.05% to -$130000.0 in 2024, then soared by 50.0% to -$65000.0 in 2025, then surged by 55.38% to -$29000.0 in 2026.
Per Business Quant, the three most recent readings for ANIK's Exchange Rate Effect are -$29000.0 (Q1 2026), -$65000.0 (Q4 2025), and -$302000.0 (Q3 2025).